Clinical Orthopaedics and Related Research®

, Volume 469, Issue 12, pp 3511–3512 | Cite as

Reply to Letter to the Editor: The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal Femur

  • Aasis Unnanuntana
  • John P. Kleimeyer
  • Kashif Ashfaq
  • Quang V. Ton
  • Joseph M. Lane
Reply to Letter to the Editor
First Online:

Keywords

Alendronate Cortical Thickness Bisphosphonate Therapy Femoral Cortex Bone Mineral Density Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Delmas PD. Treatment of postmenopausal osteoporosis. Lancet. 2002;359:2018–2026.PubMedCrossRefGoogle Scholar
  2. 2.
    Koh JS, Goh SK, Png MA, Kwek EB, Howe TS. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?. J Orthop Trauma. 2010;24:75–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009;20:1353–1362.PubMedCrossRefGoogle Scholar
  4. 4.
    Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, Norimatsu H. The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab. 2005;23(suppl):36–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Pols HA, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int. 1999;9:461–468.PubMedCrossRefGoogle Scholar
  6. 6.
    Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267–2294.Google Scholar
  7. 7.
    Unnanuntana A, Ashfaq K, Ton QV, Kleimeyer JP, Lane JM. The effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res. 2011 Jul 20. [Epub ahead of print])Google Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2011

Authors and Affiliations

  • Aasis Unnanuntana
    • 1
    • 2
  • John P. Kleimeyer
    • 3
  • Kashif Ashfaq
    • 2
  • Quang V. Ton
    • 4
  • Joseph M. Lane
    • 2
  1. 1.Department of Orthopaedic SurgerySiriraj Hospital, Mahidol UniversityBangkokThailand
  2. 2.Department of Orthopaedic SurgeryHospital for Special SurgeryNew YorkUSA
  3. 3.Weill Cornell Medical CollegeCornell UniversityNew YorkUSA
  4. 4.Department of Internal MedicineEnglewood Hospital and Medical CenterNew YorkUSA

Personalised recommendations